FI93734C - Menetelmä eukaryoottisen painolastiosan sisältävien fuusioproteiinien valmistamiseksi ja menetelmässä käyttökelpoisia tuotteita - Google Patents

Menetelmä eukaryoottisen painolastiosan sisältävien fuusioproteiinien valmistamiseksi ja menetelmässä käyttökelpoisia tuotteita

Info

Publication number
FI93734C
FI93734C FI865187A FI865187A FI93734C FI 93734 C FI93734 C FI 93734C FI 865187 A FI865187 A FI 865187A FI 865187 A FI865187 A FI 865187A FI 93734 C FI93734 C FI 93734C
Authority
FI
Finland
Prior art keywords
fusion proteins
eukaryotic
proteins containing
products useful
producing fusion
Prior art date
Application number
FI865187A
Other languages
English (en)
Swedish (sv)
Other versions
FI865187A (fi
FI865187A0 (fi
FI93734B (fi
Inventor
Paul Habermann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI865187A0 publication Critical patent/FI865187A0/fi
Publication of FI865187A publication Critical patent/FI865187A/fi
Application granted granted Critical
Publication of FI93734B publication Critical patent/FI93734B/fi
Publication of FI93734C publication Critical patent/FI93734C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI865187A 1985-12-21 1986-12-18 Menetelmä eukaryoottisen painolastiosan sisältävien fuusioproteiinien valmistamiseksi ja menetelmässä käyttökelpoisia tuotteita FI93734C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3545565 1985-12-21
DE3545565 1985-12-21
DE19863636903 DE3636903A1 (de) 1985-12-21 1986-10-30 Fusionsproteine mit eukaryotischem ballastanteil
DE3636903 1986-10-30

Publications (4)

Publication Number Publication Date
FI865187A0 FI865187A0 (fi) 1986-12-18
FI865187A FI865187A (fi) 1987-06-22
FI93734B FI93734B (fi) 1995-02-15
FI93734C true FI93734C (fi) 1995-05-26

Family

ID=25839208

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865187A FI93734C (fi) 1985-12-21 1986-12-18 Menetelmä eukaryoottisen painolastiosan sisältävien fuusioproteiinien valmistamiseksi ja menetelmässä käyttökelpoisia tuotteita

Country Status (16)

Country Link
EP (1) EP0229998B1 (fi)
JP (2) JP2553058B2 (fi)
KR (1) KR950000301B1 (fi)
AT (1) ATE78296T1 (fi)
AU (1) AU599943B2 (fi)
CA (1) CA1339894C (fi)
DE (1) DE3636903A1 (fi)
DK (1) DK168823B1 (fi)
ES (1) ES2033678T3 (fi)
FI (1) FI93734C (fi)
GR (1) GR3005985T3 (fi)
HU (1) HU209747B (fi)
IE (1) IE58935B1 (fi)
IL (1) IL81018A (fi)
NO (1) NO175003C (fi)
PT (1) PT83973B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
FR2643646B1 (fr) * 1989-02-27 1993-09-17 Pasteur Institut Expression de sequences de nucleotides codant pour des vesicules a gaz
CU22222A1 (es) * 1989-08-03 1995-01-31 Cigb Procedimiento para la expresion de proteinas heterologicas producidas de forma fusionada en escherichia coli, su uso, vectores de expresion y cepas recombinantes
DE3942580A1 (de) * 1989-12-22 1991-06-27 Basf Ag Verfahren zur herstellung von hirudin
DE4105480A1 (de) * 1991-02-21 1992-08-27 Boehringer Mannheim Gmbh Verbesserte aktivierung von rekombinanten proteinen
ATE264871T1 (de) 1996-07-26 2004-05-15 Aventis Pharma Gmbh Insulinderivate mit erhöhter zinkbindung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
KR101939557B1 (ko) 2008-10-17 2019-01-17 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 ｇｌｐ－1 효능제의 병용물
CN107308442B (zh) 2009-11-13 2022-10-18 赛诺菲-安万特德国有限公司 包含glp-1激动剂、胰岛素和甲硫氨酸的药物组合物
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
LT2611458T (lt) 2010-08-30 2016-12-27 Sanofi-Aventis Deutschland Gmbh Ave0010 panaudojimas gaminant vaistą, skirtą 2 tipo cukrinio diabeto gydymui
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
MX370264B (es) 2011-08-29 2019-12-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
KR20200080748A (ko) 2018-12-27 2020-07-07 주식회사 폴루스 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법
KR20200080747A (ko) 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
EP0158198A1 (en) * 1984-03-29 1985-10-16 Takeda Chemical Industries, Ltd. DNA and use thereof
GB8412517D0 (en) * 1984-05-16 1984-06-20 Nagai K Recombinant fusion proteins

Also Published As

Publication number Publication date
ATE78296T1 (de) 1992-08-15
DK619186D0 (da) 1986-12-19
JP2553058B2 (ja) 1996-11-13
JPS62167799A (ja) 1987-07-24
NO865192D0 (no) 1986-12-19
AU6676086A (en) 1987-06-25
IL81018A (en) 1992-03-29
EP0229998B1 (de) 1992-07-15
ES2033678T3 (es) 1993-04-01
EP0229998A3 (en) 1988-08-03
IL81018A0 (en) 1987-03-31
EP0229998A2 (de) 1987-07-29
GR3005985T3 (fi) 1993-06-07
DK168823B1 (da) 1994-06-20
KR950000301B1 (ko) 1995-01-13
IE863334L (en) 1987-06-21
IE58935B1 (en) 1993-12-01
FI865187A (fi) 1987-06-22
HUT44614A (en) 1988-03-28
JPH08187089A (ja) 1996-07-23
DE3636903A1 (de) 1987-07-02
PT83973A (de) 1987-01-01
KR870006187A (ko) 1987-07-09
NO865192L (no) 1987-06-22
DK619186A (da) 1987-06-22
NO175003B (no) 1994-05-09
PT83973B (pt) 1989-07-31
NO175003C (no) 1994-08-17
JP2774260B2 (ja) 1998-07-09
FI865187A0 (fi) 1986-12-18
CA1339894C (en) 1998-06-02
FI93734B (fi) 1995-02-15
AU599943B2 (en) 1990-08-02
HU209747B (en) 1994-10-28

Similar Documents

Publication Publication Date Title
FI93734C (fi) Menetelmä eukaryoottisen painolastiosan sisältävien fuusioproteiinien valmistamiseksi ja menetelmässä käyttökelpoisia tuotteita
PT83761B (pt) Metodo para a producao de interleuquina-4 de mamifero
FI863041A0 (fi) Fusionsprotein, foerfarande foer deras framstaellning och deras anvaendning.
ATE94754T1 (de) Verfahren und zusammensetzung zur herstellung von liposomen.
ATE113597T1 (de) Antagonisten von excitatorischen aminosäuren.
AU4838690A (en) Use of hiv protease cleavage site to express mature proteins
DK196489A (da) Carbamatderivater samt en fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: HOECHST AKTIENGESELLSCHAFT

MA Patent expired